Literature DB >> 7526802

Effect of tacrolimus (FK506) in dystrophic epidermolysis bullosa: rationale and preliminary results.

P B Carroll, H L Rilo, K Abu Elmagd, N Johnson, C Carter, H Wright, B Jegasothy, T E Starzl, D H Van Thiel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7526802     DOI： 10.1001/archderm.130.11.1457

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  2 in total

1.  Pharmacological mobilization of endogenous stem cells significantly promotes skin regeneration after full-thickness excision: the synergistic activity of AMD3100 and tacrolimus.

Authors:  Qing Lin; Russell N Wesson; Hiromichi Maeda; Yongchun Wang; Zhu Cui; Jun O Liu; Andrew M Cameron; Bin Gao; Robert A Montgomery; George M Williams; Zhaoli Sun
Journal:  J Invest Dermatol       Date:  2014-03-28       Impact factor: 8.551

Review 2.  Small molecule drug development for rare genodermatoses - evaluation of the current status in epidermolysis bullosa.

Authors:  Verena Wally; Manuela Reisenberger; Sophie Kitzmüller; Martin Laimer
Journal:  Orphanet J Rare Dis       Date:  2020-10-19       Impact factor: 4.123
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.